Wolfson Group, a Scotland-based international consumer wellness company, has announced that three of its flagship brands—PhenQ, TestoPrime, and YourBiology—will soon be available on OneLavi.com. The move marks a significant step in the company's strategy to expand U.S. distribution beyond Amazon, where these brands currently reach American consumers. For the biohacking and wellness community, this development underscores the growing mainstream acceptance of targeted supplements for weight management, men's wellbeing, and gut health, and it may signal a shift toward more diversified online retail channels for such products.
The upcoming OneLavi availability will provide another online destination for U.S. consumers to discover and purchase Wolfson Group brands. According to the founder and CEO of Wolfson Group, "Expanding onto OneLavi is another important step in making our brands more accessible to consumers across the U.S. Amazon has provided us with a strong foundation in the market, and we're now building on that presence by developing additional channels for our portfolio." This expansion is part of a broader effort to build a diversified retail and e-commerce presence in the United States, reducing reliance on a single marketplace.
The three brands represent distinct areas of the consumer wellness market. PhenQ focuses on weight management, while TestoPrime serves the men's wellbeing category. YourBiology targets women's gut health and everyday wellness. These categories align with key biohacking interests, such as optimizing metabolism, hormone balance, and digestive health. The expansion follows Wolfson Group's participation in the ECRM Vitamin, Weight Management & Sports Nutrition Session in Palm Beach Gardens, Florida, in September, where the company introduced its multi-category portfolio during scheduled retail meetings.
Wolfson Group has observed that consumer wellness interests increasingly span multiple categories, including weight management, cognitive wellness, gut health, men's and women's wellbeing, and healthy ageing. The company believes its diversified portfolio can serve consumers with different wellness priorities across various life stages. Adding OneLavi to its U.S. distribution strategy reflects an approach of building multiple paths to the consumer rather than relying on a single marketplace or retail channel. "Our U.S. strategy is about creating a broader and more sustainable distribution footprint over time," the founder said. "Adding new online retail relationships complements what we've already built and gives us another foundation as we continue exploring opportunities across both e-commerce and brick-and-mortar retail."
For biohacking enthusiasts, this announcement means greater accessibility to supplements that support performance, longevity, and optimized living. It also highlights the mainstreaming of once-niche wellness categories, potentially influencing product innovation and competition. Wolfson Group, as detailed on its Wolfson Group website, focuses on science-led brand development and consumer education, and it plans to continue pursuing additional U.S. distribution opportunities. As the wellness market evolves, such expansions may drive further integration of biohacking principles into everyday health routines.
